Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
Elisabetta Degasperi, Alessio AghemoDivision of Gastroenterology and Hepatology, AM and M Migliavacca Center, Fondazione IRCCS Ca' Granda Maggiore Hospital, University of Milan, Milan, ItalyAbstract: In recent years, clinical research in the field of new treatments for chronic hepatitis C (...
Main Authors: | Degasperi E, Aghemo A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-04-01
|
Series: | Hepatic Medicine : Evidence and Research |
Online Access: | http://www.dovepress.com/sofosbuvir-for-the-treatment-of-chronic-hepatitis-c-between-current-ev-a16599 |
Similar Items
-
Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report
by: Giovanni Covini, et al.
Published: (2018-10-01) -
Research advances in sofosbuvir for treatment of chronic hepatitis C
by: PENG Huanyan, et al.
Published: (2016-04-01) -
Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
by: Eiichi Ogawa, et al.
Published: (2020-09-01) -
SOFOSBUVIR-VELPATASVIR THERAPY IN THE TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 3
by: Arif Qayyum Khan, et al.
Published: (2021-02-01) -
Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.
by: Alena M Pfeil, et al.
Published: (2015-01-01)